title: Gene expression profiling of colon cancer reveals a broad molecular repertoire in 5-fluorouracil resistance.
authors.affiliation: VBC-Genomics Bioscience Research Inc., Vienna Austria.
authors.forename: W M
authors.initials: WM
authors.lastname: Schmidt
authors.forename: M
authors.initials: M
authors.lastname: Kalipciyan
authors.forename: E
authors.initials: E
authors.lastname: Dornstauder
authors.forename: B
authors.initials: B
authors.lastname: Rizovski
authors.forename: R
authors.initials: R
authors.lastname: Sedivy
authors.forename: G G
authors.initials: GG
authors.lastname: Steger
authors.forename: M W
authors.initials: MW
authors.lastname: Müller
authors.forename: R M
authors.initials: RM
authors.lastname: Mader
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000494:pharmacology*; D003110:Colonic Neoplasms / Q000188:drug therapy* / Q000235:genetics* / Q000473:pathology; D019008:Drug Resistance, Neoplasm; D005472:Fluorouracil / Q000494:pharmacology*; D020869:Gene Expression Profiling; D006801:Humans; D009362:Neoplasm Metastasis; D020411:Oligonucleotide Array Sequence Analysis; D012333:RNA, Messenger / Q000032:analysis; D014407:Tumor Cells, Cultured
chemical_list: D000964:Antimetabolites, Antineoplastic; D012333:RNA, Messenger; D005472:Fluorouracil